Sodium Chloride Injection 0.45% and Ustekinumab Subcutaneous
Determining the interaction of Sodium Chloride Injection 0.45% and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium chloride
Brand name: BD PosiFlush SF, Normal Saline flush, Swabflush, Syrex, Thermoject, Tip-Lok Diluent, Hyper-Sal, Nebusal, Sodium chloride, Inhalation, HyperSal, Nebusal, PulmoSal, Altachlore, Muro 128, Sochlor, Adsorbonac, AK-NaCl
Synonyms: Sodium chloride (flush), Sodium Chloride
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sodium Chloride Injection 0.45%-Ustekinumab Subcutaneous Injection
- Sodium Chloride Injection 0.45%-Ustell
- Sodium Chloride Injection 0.45%-UTA
- Sodium Chloride Injection 0.45%-UTA Capsules
- Sodium Chloride Injection 0.45%-UTAC tablets
- Sodium Chloride Injection 0.45%-UTI Relief
- Ustekinumab Subcutaneous-Sodium Chloride Injection 14.6%
- Ustekinumab Subcutaneous-Sodium Chloride Injection 23.4%
- Ustekinumab Subcutaneous-Sodium Chloride Injection 3% 5%
- Ustekinumab Subcutaneous-Sodium Chloride Injection Hospira
- Ustekinumab Subcutaneous-Sodium Chloride Injection Solution
- Ustekinumab Subcutaneous-Sodium Chloride Intravenous Infusion